← All stocks

Stock news timeline · PPLPHARMA

Piramal Pharma Ltd

News timeline · Last 30 days

23 Aug 2026 – 21 Sep 2026 · Times in IST

Timeline updates
6
Bullish
2
Neutral
2
Bearish
2
Active days
5

News timeline

Showing 6 of 6 updates · Newest first

Tuesday, 15 Sep 20261 update

AI sentiment: Bearish 59% confidence

Piramal Pharma: Co's Morpeth Facility Faces Seven Observations From US FDA Inspection.

Monday, 14 Sep 20262 updates

AI sentiment: Bearish 81% confidence

Piramal Pharma's UK Plant Gets 7 FDA Observations; Stock Dips 0.28%

Piramal Pharma's Morpeth UK facility received 7 FDA observations after GMP inspection. Shares of Piramal Pharma closed at ₹211.90, down 0.28% on the BSE. Source: CNBC TV 18

AI sentiment: Neutral 0% confidence

Piramal Pharma's UK Plant Gets FDA Form-483; 7 Issues Noted

Piramal Pharma's UK facility underwent US FDA inspection, resulting in Form-483 with 7 observations. The company is addressing these issues and preparing a detailed response for submission within timeline. Source: BSE

Tuesday, 08 Sep 20261 update

AI sentiment: Bullish 51% confidence

Piramal Pharma Sees ₹15.1 Cr Block Deal on NSE at ₹223.5/Share

Piramal Pharma Ltd. recorded an NSE block trade worth Rs. 15.1 crore. The trade involved ~676,267 shares at Rs. 223.5 per share. Source: Livesquawk

Thursday, 03 Sep 20261 update

AI sentiment: Bullish 89% confidence

Piramal Pharma's ESG Score Rises to 65 for FY26

Piramal Pharma received an ESG score of 65 for FY 2025-26, up from 64. The ESG rating, by NSE Sustainability, was based on publicly available data. Source: BSE

Wednesday, 26 Aug 20261 update

AI sentiment: Neutral 82% confidence

Deutsche Bank Pledges 17.9% Stake in Piramal Pharma, Repledges 7.4% Voting Capital

Deutsche Bank disclosed pledge of 238.7M shares of Piramal Pharma, 17.9% share capital. Repledged 98.4M shares to secure loans, constituting 7.4% voting capital. Source: BSE